The global Veterinary Renal Diseases Market is gaining momentum as veterinarians and animal owners place greater emphasis on the early detection, diagnosis, and management of renal diseases in pets and livestock.

Market Overview

The Veterinary Renal Diseases market was valued at US$ 18.36 billion in 2025 and is expected to reach US$ 30.6 billion by 2034; it is estimated to record a CAGR of 5.84% during 2026-2034.The increasing incidence of chronic kidney disease and other renal disorders, particularly among aging companion animals, is contributing to demand for veterinary renal disease diagnosis and treatment.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00040603

Veterinary Renal Diseases Market Drivers

Rising Prevalence of Kidney Disorders in Animals:

The increasing incidence of chronic kidney disease and other renal disorders, particularly among aging companion animals, is contributing to demand for veterinary renal disease diagnosis and treatment. Dogs and cats are increasingly receiving routine health screenings, enabling veterinarians to identify renal conditions at earlier stages.

Growing Companion Animal Healthcare Spending:

Higher pet ownership and increasing willingness among owners to spend on advanced veterinary care are supporting market growth. Pet owners are increasingly seeking specialized diagnostics, therapeutic diets, medications, and long-term management solutions for animals with kidney disorders.

Advancements in Veterinary Diagnostics:

Technological developments in blood testing, urinalysis, imaging, biomarkers, and other diagnostic methods are improving the detection and monitoring of renal diseases. Early diagnosis enables veterinarians to develop appropriate treatment plans and monitor disease progression more effectively.

Increasing Focus on Preventive Veterinary Care:

Greater emphasis on routine veterinary examinations and preventive healthcare is creating opportunities for renal disease screening. Regular monitoring of kidney function can help identify abnormalities before severe symptoms develop, particularly in senior and high-risk animals.

Veterinary Renal Diseases Market Opportunities

The development of innovative veterinary therapeutics, renal-supportive diets, diagnostic biomarkers, and digital monitoring technologies is creating new opportunities in the market. Growing research into the underlying mechanisms of kidney diseases in animals may also support the development of targeted treatment approaches.

Increasing adoption of specialized veterinary nutrition represents another opportunity. Prescription renal diets and nutritional supplements are widely used as part of long-term disease management, particularly for companion animals with chronic kidney conditions.

Veterinary Renal Diseases Market Segmentation

disease type, animal type, diagnosis, treatment, and end userThe market can be segmented based on .

By Disease Type:

Chronic Kidney Disease
Acute Kidney Injury
Renal Failure
Glomerular Disease
Kidney Stones
Other Renal Disorders

By Animal Type:

Dogs
Cats
Horses
Cattle
Other Animals

By Diagnosis:

Blood Tests
Urinalysis
Ultrasound
X-ray
Biomarker Testing
Other Diagnostic Methods

By Treatment:

Medications
Renal Diets
Fluid Therapy
Nutritional Supplements
Dialysis
Surgery
Other Treatments

By End User:

Veterinary Hospitals and Clinics
Veterinary Diagnostic Laboratories
Research Institutes
Specialty Veterinary Centers
Others

Veterinary Renal Diseases Market Key Players

Key companies operating in or serving the veterinary renal disease market include:

Zoetis
Mars Petcare
Hill's Pet Nutrition
IDEXX Laboratories
Royal Canin
Elanco Animal Health
Vetoquinol
Virbac
Nestlé Purina Petcare
PetCure Oncology

Regional Outlook

North America is expected to represent a significant market due to high companion animal ownership, increasing veterinary healthcare expenditure, and widespread access to advanced diagnostic and treatment services. Greater awareness of chronic kidney disease among pet owners is also supporting demand for regular screening and long-term disease management.

Europe is witnessing increasing demand for veterinary renal disease products as animal welfare awareness, preventive healthcare practices, and access to specialized veterinary services improve. The region's established veterinary infrastructure is supporting the adoption of advanced diagnostics and therapeutic solutions.

Asia Pacific is expected to experience continued growth as pet ownership increases and veterinary healthcare infrastructure develops. Rising disposable incomes, expanding veterinary clinics, and greater awareness of companion animal health are contributing to the adoption of renal disease diagnostics and treatments.

Future Outlook

Veterinary Renal Diseases MarketThe is expected to benefit from continued advances in veterinary diagnostics, therapeutic development, and nutritional management. Growing emphasis on early detection, personalized veterinary care, and long-term disease monitoring is likely to support demand for renal disease management solutions. Increasing investment in animal healthcare research and the development of innovative biomarkers and treatment approaches may further contribute to market expansion.

About US

The Insight Partners provides comprehensive syndicated and tailored market research services across the healthcare, technology, and industrial sectors. The company delivers market intelligence and strategic insights to help organizations understand emerging trends, identify growth opportunities, and make informed business decisions in rapidly evolving markets.

Contact Us

Contact Person: Ankit Mathur

E-mail:ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Chronic Kidney Disease in Companion Animals: A Major Catalyst for Market Expansion

The Veterinary Renal Diseases market was valued at US$ 18.36 billion in 2025 and is expected to reach US$ 30.6 billion by 2034.;